Litton Mark James
Insider CIK 1604834 · ALDR Chief Business Officer · ATHA President and CEO, Director · ALPN See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LONA LeonaBio, Inc. | A Award deriv | 2026-04-09 | 2026-04-13 | 750,000 | — | $0 | 750,000 | SEC↗ |
| LONA LeonaBio, Inc. | S Sale | 2026-03-04 | 2026-03-05 | 5,156 | $5.37 | $27.7K | 57,926 | SEC↗ |
| LONA LeonaBio, Inc. | M Exercise deriv | 2026-03-03 | 2026-03-05 | 22,254 | — | $0 | 0 | SEC↗ |
| LONA LeonaBio, Inc. | M Exercise | 2026-03-03 | 2026-03-05 | 22,254 | — | $0 | 63,082 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2026-01-02 | 2026-01-05 | 2,586 | $6.88 | $17.8K | 40,828 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2025-12-31 | 2026-01-05 | 10,834 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2025-12-31 | 2026-01-05 | 10,834 | — | $0 | 43,414 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-12-24 | 2025-12-29 | 133,526 | — | $0 | 133,526 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2025-07-01 | 2025-07-02 | 25,123 | $0.29 | $7.3K | 325,802 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2025-06-30 | 2025-07-02 | 108,334 | — | $0 | 108,333 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2025-06-30 | 2025-07-02 | 108,334 | — | $0 | 350,925 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 333,815 | — | $0 | 333,815 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 222,543 | — | $0 | 222,543 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 25,107 | $0.56 | $14.1K | 242,591 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-03 | 108,333 | — | $0 | 216,667 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2024-12-31 | 2025-01-03 | 108,333 | — | $0 | 267,698 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-10-03 | 2024-10-03 | 325,000 | — | $0 | 325,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-10-03 | 2024-10-03 | 325,000 | — | $0 | 325,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-10-03 | 2024-10-03 | 325,000 | — | $0 | 325,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2024-09-05 | 2024-09-05 | 5,032 | $0.57 | $2.9K | 159,365 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-09-03 | 2024-09-05 | 20,000 | — | $0 | 164,397 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-02-15 | 2024-02-16 | 650,000 | — | $0 | 650,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2024-01-05 | 2024-01-08 | 4,820 | $2.91 | $14.0K | 144,397 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2024-01-05 | 2024-02-16 | 4,820 | $2.91 | $14.0K | 144,397 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-01-04 | 2024-01-08 | 20,000 | — | $0 | 149,217 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-01-04 | 2024-02-16 | 20,000 | — | $0 | 149,217 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2023-01-27 | 2023-01-31 | 425,000 | — | $0 | 425,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2022-11-18 | 2023-01-31 | 662 | $2.74 | $1.8K | 129,217 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2022-06-23 | 2022-06-24 | 7,960 | $2.69 | $21.4K | 128,555 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2022-06-22 | 2022-06-24 | 20,000 | — | $0 | 136,515 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2022-05-18 | 2022-06-24 | 757 | $7.06 | $5.3K | 116,515 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2022-01-27 | 2022-01-31 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2021-11-18 | 2022-01-31 | 885 | $12.51 | $11.1K | 115,758 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2021-08-17 | 2021-08-19 | 50,440 | — | $0 | 100,880 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2021-08-17 | 2021-08-19 | 50,440 | $1.35 | $68.1K | 114,873 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2021-05-18 | 2021-08-19 | 867 | $14.45 | $12.5K | 64,433 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2021-02-18 | 2021-02-22 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | C Conversion deriv | 2020-09-22 | 2020-09-22 | 6,563 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | C Conversion deriv | 2020-09-22 | 2020-09-22 | 13,126 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | C Conversion deriv | 2020-09-22 | 2020-09-22 | 6,563 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | C Conversion deriv | 2020-09-22 | 2020-09-22 | 6,563 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | C Conversion | 2020-09-22 | 2020-09-22 | 6,563 | — | $0 | 6,563 | SEC↗ |
| ATHA Athira Pharma, Inc. | C Conversion | 2020-09-22 | 2020-09-22 | 6,563 | — | $0 | 6,563 | SEC↗ |
| ATHA Athira Pharma, Inc. | C Conversion | 2020-09-22 | 2020-09-22 | 13,126 | — | $0 | 63,566 | SEC↗ |
| ATHA Athira Pharma, Inc. | C Conversion | 2020-09-22 | 2020-09-22 | 6,563 | — | $0 | 6,563 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2019-02-06 | 2019-02-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2019-02-06 | 2019-02-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2018-08-06 | 2018-08-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2018-06-01 | 2018-06-05 | 22,727 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2018-06-01 | 2018-06-05 | 4,474 | $18.24 | $81.6K | 102,189 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2018-06-01 | 2018-06-05 | 22,727 | $0.99 | $22.5K | 124,916 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2018-06-01 | 2018-06-05 | 18,253 | $17.74 | $323.8K | 106,663 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2018-02-16 | 2018-02-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2017-11-13 | 2017-11-15 | 16,519 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2017-11-13 | 2017-11-15 | 16,519 | $1.65 | $27.3K | 116,451 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2017-11-13 | 2017-11-15 | 16,519 | $10.80 | $178.4K | 99,932 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2017-10-16 | 2017-10-18 | 16,520 | — | $0 | 16,519 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2017-10-16 | 2017-10-18 | 16,520 | $12.33 | $203.7K | 99,932 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2017-10-16 | 2017-10-18 | 16,520 | $1.65 | $27.3K | 116,452 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2017-01-27 | 2017-01-31 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2017-01-18 | 2017-01-20 | 1,498 | — | $0 | 33,039 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2017-01-18 | 2017-01-20 | 1,498 | $23.10 | $34.6K | 99,932 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2017-01-18 | 2017-01-20 | 1,498 | $1.65 | $2.5K | 101,430 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2017-01-09 | 2017-01-09 | 500 | — | $0 | 34,537 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2017-01-09 | 2017-01-09 | 500 | $23.00 | $11.5K | 99,932 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2017-01-09 | 2017-01-09 | 500 | $1.65 | $825 | 100,432 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2017-01-06 | 2017-01-09 | 1,326 | — | $0 | 35,037 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2017-01-06 | 2017-01-09 | 5,474 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2017-01-06 | 2017-01-09 | 6,800 | $23.02 | $156.5K | 99,932 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2017-01-06 | 2017-01-09 | 1,326 | $1.65 | $2.2K | 106,732 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2017-01-06 | 2017-01-09 | 5,474 | $1.27 | $7.0K | 105,406 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2017-01-05 | 2017-01-09 | 2,216 | — | $0 | 5,474 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2017-01-05 | 2017-01-09 | 2,216 | $23.00 | $51.0K | 99,932 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2017-01-05 | 2017-01-09 | 2,216 | $1.27 | $2.8K | 102,148 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-10-17 | 2016-10-19 | 2,000 | $27.50 | $55.0K | 26,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-10-17 | 2016-10-19 | 2,000 | $27.50 | $55.0K | 26,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-10-17 | 2016-10-19 | 2,000 | $27.50 | $55.0K | 26,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2016-07-12 | 2016-07-14 | 25,000 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2016-07-12 | 2016-07-14 | 25,000 | $0.39 | $9.8K | 99,567 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-06-13 | 2016-06-15 | 1,900 | $28.90 | $54.9K | 28,100 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-06-13 | 2016-06-15 | 100 | $29.60 | $3.0K | 28,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-06-13 | 2016-06-15 | 1,900 | $28.89 | $54.9K | 28,100 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-06-13 | 2016-06-15 | 100 | $29.60 | $3.0K | 28,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-06-13 | 2016-06-15 | 1,800 | $28.90 | $52.0K | 28,200 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-06-13 | 2016-06-15 | 200 | $29.64 | $5.9K | 28,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2016-05-31 | 2016-06-01 | 19,720 | — | $0 | 25,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2016-05-31 | 2016-06-01 | 19,720 | $0.39 | $7.7K | 94,287 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-05-31 | 2016-06-01 | 19,720 | $30.05 | $592.6K | 74,567 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2016-05-27 | 2016-06-01 | 5,280 | — | $0 | 44,720 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-05-27 | 2016-06-01 | 5,280 | $30.06 | $158.7K | 74,567 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2016-05-27 | 2016-06-01 | 5,280 | $0.39 | $2.1K | 79,847 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2016-01-29 | 2016-02-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2016-01-04 | 2016-01-06 | 25,000 | — | $0 | 50,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-01-04 | 2016-01-06 | 7,709 | $31.86 | $245.6K | 73,718 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2016-01-04 | 2016-01-06 | 17,291 | $31.19 | $539.3K | 81,427 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2016-01-04 | 2016-01-06 | 25,000 | $0.39 | $9.8K | 98,718 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2015-10-01 | 2015-10-05 | 560 | $32.81 | $18.4K | 72,919 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2015-10-01 | 2015-10-05 | 6,940 | $32.22 | $223.6K | 73,479 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2015-09-24 | 2015-09-28 | 12,764 | — | $0 | 7,690 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2015-09-24 | 2015-09-28 | 12,764 | $1.27 | $16.2K | 80,419 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2015-07-01 | 2015-07-06 | 7,500 | $51.10 | $383.3K | 67,655 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise deriv | 2015-06-04 | 2015-06-08 | 25,000 | — | $0 | 75,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | M Exercise | 2015-06-04 | 2015-06-08 | 25,000 | $0.39 | $9.8K | 100,155 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2015-06-04 | 2015-06-08 | 25,000 | $44.27 | $1.11M | 75,155 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2015-04-01 | 2015-04-03 | 7,500 | $27.41 | $205.6K | 74,359 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2015-01-27 | 2015-01-28 | 2,300 | $28.52 | $65.6K | 81,859 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2015-01-26 | 2015-01-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2015-01-26 | 2015-01-28 | 5,200 | $28.03 | $145.8K | 84,159 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | S Sale | 2014-11-20 | 2014-11-24 | 30,000 | $15.63 | $468.9K | 88,484 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2014-07-08 | 2014-07-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2014-05-07 | 2014-05-09 | 9,090 | — | $0 | 9,090 | SEC↗ |